Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Therapeutics PLC

20.79
+1.608.34%
Post-market: 20.880.0881+0.42%19:59 EDT
Volume:3.23M
Turnover:66.24M
Market Cap:15.34B
PE:-67.06
High:21.30
Open:19.49
Low:19.20
Close:19.19
Loading ...

Company Profile

Company Name:
Summit Therapeutics PLC
Exchange:
NASDAQ
Establishment Date:
2003
Employees:
159
Office Location:
601 Brickell Key Drive,Suite 1000,Miami,Florida,United States
Zip Code:
33131
Fax:
- -
Introduction:
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. The company's lead development candidate is Ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis; and anti-infectives portfolio includes SMT-738, a novel class of precision antibiotics for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. and its affiliates to develop and commercialize ivonescimab, as well as strategic collaboration with The University of Texas MD Anderson Cancer Center for the purpose of accelerating the development of ivonescimab. The company was founded in 2003 and is headquartered in Miami, Florida.

Directors

Name
Position
Frank Armstrong
Non-Executive Chairman
Glyn Edwards
Chief Executive Officer, Executive Director
Barry Price
Non-Executive Director
David Wurzer
Non-Executive Director
Leopoldo Zambeletti
Non-Executive Director
Stephen Davies
Non-Executive Director
Valerie Andrews
Non-Executive Director

Shareholders

Name
Position
Glyn Edwards
Chief Executive Officer, Executive Director
David Roblin
Chief Operating Officer and President of Research and Development
Erik Ostrowski
Chief Financial Officer
Jonathon Tinsley
Chief Scientific Officer, DMD
Ralf Rosskamp
Chief Medical Officer
Richard Vickers
Chief Scientific Officer, Antimicrobials